These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15753763)

  • 1. Inotropic options for postresuscitation myocardial dysfunction.
    Gazmuri RJ; Kolarova JD; Ayoub IM
    Crit Care Med; 2005 Mar; 33(3):668-70. PubMed ID: 15753763
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison between dobutamine and levosimendan for management of postresuscitation myocardial dysfunction.
    Huang L; Weil MH; Tang W; Sun S; Wang J
    Crit Care Med; 2005 Mar; 33(3):487-91. PubMed ID: 15753736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levosimendan improves postresuscitation outcomes in a rat model of CPR.
    Huang L; Weil MH; Sun S; Cammarata G; Cao L; Tang W
    J Lab Clin Med; 2005 Nov; 146(5):256-61. PubMed ID: 16242524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levosimendan in regional myocardial ischemia.
    Pieske B
    Cardiovasc Drugs Ther; 2002 Sep; 16(5):379-81. PubMed ID: 12656119
    [No Abstract]   [Full Text] [Related]  

  • 5. Levosimendan and gut mucosal blood flow--not all inotropes are created equal.
    Coopersmith CM
    Crit Care Med; 2005 Jan; 33(1):246-7. PubMed ID: 15644686
    [No Abstract]   [Full Text] [Related]  

  • 6. Levosimendan in cardiac surgery: a unique drug for the treatment of perioperative left ventricular dysfunction or just another inodilator searching for a clinical application?
    Pagel PS
    Anesth Analg; 2007 Apr; 104(4):759-61. PubMed ID: 17377077
    [No Abstract]   [Full Text] [Related]  

  • 7. Levosimendan improves postresuscitation myocardial dysfunction after beta-adrenergic blockade.
    Wang J; Weil MH; Tang W; Sun S; Huang L
    J Lab Clin Med; 2005 Sep; 146(3):179-83. PubMed ID: 16131457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium sensitization as new principle of inotropic therapy in end-stage heart failure?
    Zimmermann N; Boknik P; Gams E; Herzig JW; Neumann J; Scholz H
    Eur J Cardiothorac Surg; 1998 Jul; 14(1):70-5. PubMed ID: 9726618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levosimendan for heart-operated patients: what is the state of the art?
    Tagarakis GI; Tsilimingas NB
    Recent Pat Cardiovasc Drug Discov; 2009 Jan; 4(1):22-4. PubMed ID: 19149702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levosimendan versus an intra-aortic balloon pump in adult cardiac surgery patients with low cardiac output.
    Elahi MM; Lam J; Asopa S; Matata BM
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):1154-62. PubMed ID: 21376634
    [No Abstract]   [Full Text] [Related]  

  • 11. Levosimendan.
    Kamath SR; Jaykumar I; Matha S
    Indian Pediatr; 2009 Jul; 46(7):593-6. PubMed ID: 19638658
    [No Abstract]   [Full Text] [Related]  

  • 12. Resuscitation from adrenaline resistant electro-mechanical dissociation facilitated by levosimendan in a young man with idiopathic dilated cardiomyopathy.
    Tsagalou EP; Nanas JN
    Resuscitation; 2006 Jan; 68(1):147-9. PubMed ID: 16325323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levosimendan: right for the right ventricle?
    Lambermont B; Ghuysen A; Harstein G; D'Orio V
    Crit Care Med; 2007 Aug; 35(8):1995-6. PubMed ID: 17667254
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of post resuscitation myocardial dysfunction: aortic counterpulsation versus dobutamine.
    Tennyson H; Kern KB; Hilwig RW; Berg RA; Ewy GA
    Resuscitation; 2002 Jul; 54(1):69-75. PubMed ID: 12104111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levosimendan improves renal function in acute decompensated heart failure: cause and clinical application. Editorial to: "Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine by Yilmaz et al.".
    Damman K; Voors AA
    Cardiovasc Drugs Ther; 2007 Dec; 21(6):403-4. PubMed ID: 18030611
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacologic treatment of heart failure due to ventricular dysfunction by myocardial stunning: potential role of levosimendan.
    García González MJ; Domínguez Rodríguez A
    Am J Cardiovasc Drugs; 2006; 6(2):69-75. PubMed ID: 16555860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxygen-wasting effect of inotropy: is there a need for a new evaluation? An experimental large-animal study using dobutamine and levosimendan.
    Müller S; How OJ; Jakobsen Ø; Hermansen SE; Røsner A; Stenberg TA; Myrmel T
    Circ Heart Fail; 2010 Mar; 3(2):277-85. PubMed ID: 20018954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levosimendan in acute pulmonary embolism.
    Powell BP; Simes D
    Anaesth Intensive Care; 2007 Oct; 35(5):771-2. PubMed ID: 17933166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics.
    García-González MJ; Domínguez-Rodríguez A; Ferrer-Hita JJ; Abreu-González P; Muñoz MB
    Eur J Heart Fail; 2006 Nov; 8(7):723-8. PubMed ID: 16492404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive inotropy for acute heart failure complicating myocardial infarction.
    Coats AJ
    Eur Heart J; 2002 Sep; 23(18):1405-6. PubMed ID: 12208215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.